175 related articles for article (PubMed ID: 34371769)
1. Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019.
Wang N; Brickute D; Braga M; Barnes C; Lu H; Allott L; Aboagye EO
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371769
[TBL] [Abstract][Full Text] [Related]
2. The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.
Trousil S; Kaliszczak M; Schug Z; Nguyen QD; Tomasi G; Favicchio R; Brickute D; Fortt R; Twyman FJ; Carroll L; Kalusa A; Navaratnam N; Adejumo T; Carling D; Gottlieb E; Aboagye EO
Oncotarget; 2016 Jun; 7(24):37103-37120. PubMed ID: 27206796
[TBL] [Abstract][Full Text] [Related]
3. The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.
Sikandar S; Dizon D; Shen X; Li Z; Besterman J; Lipkin SM
Oncotarget; 2010 Nov; 1(7):596-605. PubMed ID: 21317455
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of a Highly Improved Anticancer Prodrug Activated by Histone Deacetylases and Cathepsin L.
Ueki N; Wang W; Swenson C; McNaughton C; Sampson NS; Hayman MJ
Theranostics; 2016; 6(6):808-16. PubMed ID: 27162551
[TBL] [Abstract][Full Text] [Related]
5. Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.
Asim M; Massie CE; Orafidiya F; Pértega-Gomes N; Warren AY; Esmaeili M; Selth LA; Zecchini HI; Luko K; Qureshi A; Baridi A; Menon S; Madhu B; Escriu C; Lyons S; Vowler SL; Zecchini VR; Shaw G; Hessenkemper W; Russell R; Mohammed H; Stefanos N; Lynch AG; Grigorenko E; D'Santos C; Taylor C; Lamb A; Sriranjan R; Yang J; Stark R; Dehm SM; Rennie PS; Carroll JS; Griffiths JR; Tavaré S; Mills IG; McEwan IJ; Baniahmad A; Tilley WD; Neal DE
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26657335
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.
Ma G; Severic M; Barker M; Pereira S; Ruiz A; Cheung CCL; Al-Jamal WT
Acta Biomater; 2021 Oct; 134():559-575. PubMed ID: 34274531
[TBL] [Abstract][Full Text] [Related]
8. Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis.
Wu G; Aoyama C; Young SG; Vance DE
J Biol Chem; 2008 Jan; 283(3):1456-1462. PubMed ID: 18029352
[TBL] [Abstract][Full Text] [Related]
9. Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors.
Vaidyanathan G; Kang CM; McDougald D; Minn I; Brummet M; Pomper MG; Zalutsky MR
Nucl Med Biol; 2018; 62-63():18-30. PubMed ID: 29803076
[TBL] [Abstract][Full Text] [Related]
10. MALAT1 as a Regulator of the Androgen-Dependent Choline Kinase A Gene in the Metabolic Rewiring of Prostate Cancer.
De Martino S; Iorio E; Cencioni C; Aiello A; Spallotta F; Chirico M; Pisanu ME; Grassi C; Pontecorvi A; Gaetano C; Nanni S; Farsetti A
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740569
[TBL] [Abstract][Full Text] [Related]
11. Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.
Challapalli A; Trousil S; Hazell S; Kozlowski K; Gudi M; Aboagye EO; Mangar S
J Clin Pathol; 2015 Sep; 68(9):703-9. PubMed ID: 26041862
[TBL] [Abstract][Full Text] [Related]
12. Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists.
Debnath S; Hao G; Guan B; Thapa P; Hao J; Hammers H; Sun X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806163
[TBL] [Abstract][Full Text] [Related]
13. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers.
Murce E; de Blois E; van den Berg S; de Jong M; Seimbille Y
R Soc Open Sci; 2023 Mar; 10(3):220950. PubMed ID: 36908985
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of
Lu K; Zhang C; Zhang Z; Kuo HT; Colpo N; Bénard F; Lin KS
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446782
[TBL] [Abstract][Full Text] [Related]
16. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
[TBL] [Abstract][Full Text] [Related]
17. A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile.
Boinapally S; Ahn HH; Cheng B; Brummet M; Nam H; Gabrielson KL; Banerjee SR; Minn I; Pomper MG
Sci Rep; 2021 Mar; 11(1):7114. PubMed ID: 33782486
[TBL] [Abstract][Full Text] [Related]
18. Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer.
Wang X; Shirke A; Walker E; Sun R; Ramamurthy G; Wang J; Shan L; Mangadlao J; Dong Z; Li J; Wang Z; Schluchter M; Luo D; Wang Y; Stauffer S; Brady-Kalnay S; Hoimes C; Lee Z; Basilion JP
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499427
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.
Miyake T; Parsons SJ
Oncogene; 2012 Mar; 31(11):1431-41. PubMed ID: 21822308
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer - a review of patent literature.
Ha H; Kwon H; Lim T; Jang J; Park SK; Byun Y
Expert Opin Ther Pat; 2021 Jun; 31(6):525-547. PubMed ID: 33459068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
